Patent · US Active

Substituted pyrazolopyrimidines as Akt kinase inhibitors

US9370517B2 · kind B2 · utility

2Cited by

0References

8Claims

0Family size

Assignees

Bayer Intellectual Property GmbH · DE
Bayer Pharma Aktiengesellschaft · DE

Inventors

Lars Bärfacker · Oberhausen, DE
William Scott · Guilford, US
Andrea Hägebarth · Berlin, DE
Hartmut Rehwinkel · Berlin, DE
Oliver Politz · Panketal, DE
Roland Neuhaus · Berlin, DE
Ulf Bömer · Glienicke, DE

Key dates

Filing date	Jan 8, 2013
Grant date	Jun 21, 2016
Priority date	—
Expiry date	Jan 8, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I) which are effective inhibitors of the Pi3K/Akt pathway, processes for their production and their use as pharmaceuticals.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.